Escondido, CA, United States of America

Azra Pervin

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 154(Granted Patents)


Location History:

  • San Diego, CA (US) (2004)
  • San Marcos, CA (US) (2002 - 2007)
  • Escondido, CA (US) (2009)

Company Filing History:


Years Active: 2002-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Visionary Work of Azra Pervin in Technology Innovation

Introduction:

Azra Pervin, a distinguished inventor based in Escondido, CA, has made significant contributions to the field of technology through his innovative spirit and dedication to creating positive impacts with his inventions.

Latest Patents:

Azra Pervin holds a commendable total of 5 patents, with his latest inventions focusing on advancing the field of medicine. One of his recent patents includes "4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis," showcasing his commitment to developing treatments for conditions involving abnormal cell growth.

Career Highlights:

Having worked at companies like Cytovia, Inc. and Biocept, Inc., Azra Pervin has honed his skills and expertise in technology innovation. His innovative mindset and scientific knowledge have led to breakthroughs in the medical field, particularly in inducing cell death in various clinical conditions.

Collaborations:

Throughout his career, Azra Pervin has collaborated with esteemed professionals such as Sui Xiong Cai and John A Drewe. These collaborations have enabled him to exchange ideas, drive innovation, and bring novel inventions to life.

Conclusion:

Azra Pervin's visionary work in technology innovation, especially in the realm of medical advancements, cements his legacy as a true pioneer in the field. His inventions not only showcase his technical prowess but also reflect his passion for positively impacting society through innovation and scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…